SEC Filings TLDR Banner

Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.

Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.

Filter by Form Type:
All346-K8-K10-Q144Schedule 13GSchedule 13G/ASchedule 13DSchedule 13D/A
Industry:Biotechnologyβœ•
Previous Page1213141516171819Next Page
2026-08-27ERNA3Form 3 Filing for Ernexa Therapeutics Inc.MEDIUM
This filing reports the initial ownership of securities by David Polinsky, a director at Ernexa Therapeutics Inc. (ERNA). Polinsky, through Polo3K, LLC, holds 8,000 shares of Common Stock. Additionally, he holds a warrant to purchase 8,000 shares of Common Stock, with an exercise price of $17.00. The warrant is set to ...
Nano CapBiotechnology
Previous Page1213141516171819Next Page